Le Lézard
Classified in: Health
Subject: AVO

Talc-Cancer Lawsuits Play Critical Role in Exposing Johnson & Johnson's Unethical Experiments on Prisoners


NEW BRUNSWICK, N.J., March 9, 2022 /PRNewswire/ -- Revelations that Johnson & Johnson (NYSE: JNJ) paid scientific researchers to conduct unethical and inhumane experiments on prisoners in the 1960s are shedding new light on what the company knew about cancer risks from its talc-based products like the iconic Johnson's Baby Powder, just as the company is moving to shut down jury trials in a controversial bankruptcy gambit.

Details about experiments paid for by J&J at Holmesburg Prison in Pennsylvania in the 1960s are coming to light only because cancer victims have been allowed to seek justice through their Seventh Amendment right to a jury trial, says trial lawyer Majed Nachawati, founder of Dallas-based Fears Nachawati. Future trials are in jeopardy now that J&J has initiated a controversial bankruptcy in which tens of thousands of cancer lawsuits have been transferred to a shell company that has since declared bankruptcy.

Mr. Nachawati's law firm represents numerous women who have been diagnosed with ovarian cancer after years of using Johnson's Baby Powder and other talc products produced by the company. He called on lawmakers to write legislation that would close the loophole that allows profitable companies to shed their legal liabilities in bankruptcy.

"Every cancer victim has a right to have their case heard by a jury," he says. "The idea that bankruptcy laws were passed to allow a Fortune 20 company to shed its liability through bankruptcy when that company is not in financial distress is concerning and renders toothless the right to a trial by jury. Americans should call on all lawmakers to prohibit the reprehensible conduct that Johnson & Johnson and its shell companies have implemented by filing bankruptcy."

Revelations reported by Bloomberg News show that J&J funded research in which primarily African-American inmates were injected with talc or asbestos to study their bodies' reactions. The reports indicate that J&J was aware of the health risks of its talc products for decades but has never placed a warning label on those products

"The world needs to know, and litigation is the only way that this information is coming out," Mr. Nachawati says.

Fears Nachawati Law Firm represents individuals in mass-tort litigation, businesses and governmental entities in contingent litigation and individual victims in complex personal injury litigation. One of the largest and most diverse products liability law firms in the nation, Fears Nachawati was ranked No. 1 nationally in products liability filings in federal court over the past three years, according to Lex Machina. For more information visit https://www.fnlawfirm.com.       

Contact: 
Robert Tharp 
214-420-6011 
[email protected] 

 

SOURCE Fears Nachawati Law Firm


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: